Since the first draft of the human genome sequence was released in 2001, unprecedentedly rapid progress has been made in whole genome-wide approaches by utilizing next-generationsequencing technologies. The last decade alone has generated enormous data in the forms of exome sequencing, transcriptomes, transcription factor occupancy, genomic variation profiling and epigenetic modifications. One of the most striking realizations from sequencing studies has been the discovery and characterization of non-coding RNAs (ncRNAs). Although the extent to which ncRNAs are functional in vivo is still a controversial topic, there is at least a consensus that some ncRNAs are functional and that they play various roles in biology. Among the several kinds of ncRNAs, long ncRNAs (lncRNAs) in particular have received more attention because they have a larger potential to act as multifunctional regulators. Not surprisingly, researchers in the field of immunology have started to examine ncRNAs as new regulatory mechanisms. In this review, we will summarize some lncRNAs that have been reported to function in the immune system and then argue that there is still a long way to go before we can achieve a complete understanding of lncRNAs.
Introduction
The 'RNA World' hypothesis predicts that RNAs acted as the major biological component in the early days of the evolutionary history of life by functioning as both genetic materials and catalytic factors. However, with the progress of evolution, the diversity of the functions of RNAs could have gradually reduced to acquire DNA, which is modified from RNA but possesses superior stability for better storage of genetic information. The catalytic attributes of RNA could also have been substituted by those of protein enzymes that have more efficient catalytic capabilities. Therefore, the main function of RNAs has been thought to be as messenger RNAs (mRNAs) to deliver the coding information stored on DNA to ribosomes for translation.
However, some RNAs such as transfer RNA (tRNAs), ribosomal RNAs (rRNAs), small nuclear RNAs (snRNAs; also referred to as spliceosomal RNAs) and small nucleolar RNAs (snoRNAs) retained unique molecular functions because they were too critical to be easily replaced during evolution. These minor RNAs with simple yet critical and conserved functions were classified as non-coding RNAs (ncRNAs) to distinguish them from mRNAs. Although there was evidence indicating that there are some other non-coding transcripts, they have been considered to be junk from random transcriptional activities.
The discovery of a class of ncRNAs called micro-RNAs (miRNAs) in 1993 revolutionized but complicated our understanding of ncRNAs and gene regulation (1). miRNAs are small ncRNAs processed by Drosha from long primary transcripts. After being exported to the cytosol, miRNA precursors with the hairpin structure are again cleaved by Dicer, which removes the loop portion, thus generating double-stranded RNA molecules that are 22 nucleotides long. One of the two strands is then attached to one of the Argonaute proteins to become the core part of the miRISC (miRNA-induced silencing complex). As a part of the miRISC effector complex, the miRNA base-pairs with target sequences on RNAs to mediate RNA degradation and/or translation inhibition. It is generally believed that up to 80% of all genes in the genome are regulated by miRNAs at some stage and to some extent (2) .
As technologies that detect and quantify RNAs dramatically advanced in the 2000s, it became evident that there are many more transcripts that are generated from the genome in the forms of enhancer-derived, promoter-associated, intronic, anti-sense or intergenic transcripts than was previously thought. In particular, the sequencing of the human genome in 2001 (3) as well as the human transcriptome in 2005 (4) astonishingly revealed that most of the genome is transcribed to some extent, but that the majority of it actually does not encode proteins (5) .
These observations suggested that there must exist enormous kinds of non-coding transcripts in our cells. Unfortunately, there is still no consensus about how many of these non-coding transcripts are biologically functional and not just waste transcripts that are remainders of noisy transcriptional activities. Some researchers even argue that the transcriptional activity, but not the transcript itself as its product, serves the function of ncRNAs. However, mounting evidence suggests that at least some functional ncRNAs do exist. For example, the recent results of genome-wide associated studies (GWAS) showed that many mutations related to human diseases occur outside the coding regions. In addition, the complexity of organisms is likely to be correlated with the increase in the complexity of ncRNAs, and not that of coding RNAs (6) . In fact, human beings seem to have a higher number of ncRNAs than coding genes (7). These observations strongly suggest that some ncRNAs must be functional.
The term lncRNA (long ncRNA) refers to ncRNAs that are longer than 200 nucleotides in length. It should be noted that the arbitrary 200-nucleotide cutoff was simply derived from the RNA isolation protocols used to separate shorter transcripts such as miRNAs from longer transcripts. Unlike miRNAs, which seem to work mostly in the cytosol, most lncRNAs appear to function in the nucleus, indicating that lncRNAs are unique in terms of their cellular localization compared with miRNAs.
Most lncRNAs resemble mRNAs from the point of view of biosynthesis, since most of them are generated by RNA polymerase II with introns, followed by the modifications of the 5′ cap and poly(A) tail. The molecular mechanisms by which lncRNAs regulate gene expression also resemble those of proteins since they also modulate chromatin structures, transcriptional initiation, RNA processing and translation ( Fig. 1 ) (8) . A key distinguishing feature of lncRNAs is that they display higher specific spatio-temporal expression patterns than coding RNAs, which might confer the additional complexity of molecular mechanisms required for higher organisms. Detailed characterization of lncRNAs has just begun only in the last decade, and we are now just starting to understand their involvement in diverse biological processes.
It should be mentioned here that some lncRNAs are sometimes referred to as lincRNAs (long intergenic ncRNAs) if they are located in intergenic regions without overlapping with other genes. In our review, we will only use the term 'lncRNAs' regardless of the locations unless the original authors named the identified ncRNA as 'lincRNA'. It also should be stated that this review is based on the assumption that most lncRNAs are structural and functional transcripts. In this review, we will try to summarize and discuss lncRNAs that have been reported to participate in hematopoiesis and immune responses [see also previous reviews (9) (10) (11) (12) ]. In particular, we will focus on lncRNAs that are expressed by hematopoietic cells (Fig. 2) , thus excluding many lncRNAs that are expressed by epithelial cells, even though they still can influence immune responses.
Roles of lncRNAs during hematopoiesis
In this section, we will discuss lncRNAs that have been found to be expressed in hematopoietic stem cells (HSCs) and progenitor cells and thus regulate hematopoiesis. Since we have yet to find solid evidence, we will skip the discussion for lncRNAs during lymphopoiesis.
Hematopoietic stem cells
Most lncRNAs have been reported to show higher tissue and developmental stage specificities than protein-coding mRNAs. Although lncRNAs show much lower expression levels in general, most types of cells express them (13, 14) . HSCs in the bone marrow are not an exception, and several lncRNAs such as lncRNA H19, LncHSC-1 and LncHSC-2 have been reported to be specifically expressed by HSCs (15) (16) (17) .
LncRNA H19 is expressed within a conserved gene cluster of imprinted genes, referred to as the IGN (imprinted gene network) in the early stages of HSC differentiation. Once expressed, lncRNA H19 binds with a protein partner MBD1 (a DNA-methylation-dependent transcriptional repressor) to repress target genes such as Igf2 in the IGN cluster, presumably by bringing the MBD1 to the DMR At the simplest level, lncRNAs can merely provide a molecular platform (scaffold) on which other functional macromolecules are assembled. This scaffolding is mediated by the sophisticated tertiary structure of lncRNAs. Similarly, the structure of lncRNAs can be used to inhibit protein-protein interplay by interacting with a protein as a decoy or shield. In addition to these structural roles resembling protein enzymes, lncRNAs have another great feature to offer: they can directly base-pair with DNA and RNA. This capability enables lncRNAs to function just like miRNAs by base-pairing with the 3′ UTR region of target mRNAs. Also, lncRNA can base-pair with DNA of the target loci to guide protein cofactors or signal by themselves.
(differentially methylated region). LncRNA H19 is also interesting, since it is localized in both the cytoplasm and the nucleus, a rare cellular distribution pattern compared with that of other lncRNAs.
LncHSC-1/2 lncRNAs are expressed early during hematopoiesis, and knockdown of LncHSC-1/2 compromises stem cell proliferation, indicating that they regulate the self-renewal of HSCs. Recent studies suggest that anti-sense transcripts are transcribed from a third of all genes in the genome, indicating that anti-sense transcription is a very common phenomenon (18) . For example, a study discovered that an lncRNA is expressed in HSCs as an anti-sense transcript against an mRNA encoding PU.1, a critical transcription factor for hematopoiesis (19) . Both the knockout and the knockdown of the PU.1 anti-sense transcript in cell lines suggested that this transcript functions to inhibit the translation of the coding transcript of PU.1, similarly to miRNAs.
Erythropoiesis
Interestingly, erythropoiesis seems to be regulated by a more complicated network of lncRNAs. A screening of erythroblasts from humans and mice revealed >1000 unique lncRNAs. Knockdown assays indicated that among these lncRNAs, 21 show very strong expression and 7 have positive regulatory roles in terminal erythropoiesis. Interestingly, six of the seven lncRNAs with a positive regulatory role showed no humanmouse conservation, indicating that conservation is a poor criterion for the identification of functional lncRNAs (20) .
Another global transcriptome approach also indicated that >500 potential lncRNAs are dynamically expressed during the erythropoiesis of mouse fetal liver cells (from erythrocyte progenitors to mature erythroblasts). Several selection criteria such as erythrocyte-specific expression and binding of transcription factors important for erythropoiesis narrowed down the list to 12 lncRNAs.
The knockdown of these lncRNAs using short hairpin RNAs (shRNAs) resulted in changes in the expression of many genes important for the erythroid maturation process, thus inhibiting erythrocyte maturation (21) . For example, an lncRNA named alncRNA-EC7 was found to have been transcribed from an enhancer that activates the gene encoding BAND3, a major anion-exchange protein expressed on erythrocytes (20, 21) . Knockdown of alncRNA-EC7 confirmed that it is necessary for BAND3 expression to ensure erythrocyte maturation. However, it is not clear whether it is categorized as a typical lncRNA or as an enhancer-driven RNA (eRNA) of BAND3 because it has the features of both. It is transcribed from a conserved enhancer and is spliced and poly-adenylated after transcription, all of which are features of lncRNAs. On the other hand, it is located directly on the enhancer of BAND3 and shows bidirectional transcription with widespread H3K4me1/H3K27Ac epigenetic marks, all of which are hallmarks of eRNAs. Further studies will be necessary to decipher the true nature of alncRNA-EC7.
Another lncRNA, named LincRNA-EPS (erythroid prosurvival), was discovered during a screening of differentially expressed lncRNA transcripts from mouse HSCs to erythroid progenitors (22) . Among 500 candidate lncRNAs, the authors focused on LincRNA-EPS, since high expression of LincRNA-EPS was detected during all the stages of erythrocyte development, but the expression was especially higher at the terminal differentiation stage. It was suggested that LincRNA-EPS is required to confer an anti-apoptotic activity by negatively regulating the expression of a pro-apoptotic gene named Pycard through direct RNA-DNA binding.
Myelopoiesis
Similar to erythropoiesis, myelopoiesis has been shown to require several lncRNAs. For example, an lncRNA called EGO (eosinophil granule ontology) is expressed specifically by developing eosinophil precursors in the bone marrow. The EGO is transcribed from an intron of the ITPR1 (inositol 1,4,5-trisphosphate receptor type 1) locus (23) . Stimulation of hematopoietic progenitors by IL-5, a differentiation cytokine for eosinophils, sharply induces EGO transcription. Knockdown experiments for EGO showed that EGO regulates the differentiation of eosinophils in part by positively regulating several genes important for eosinopoiesis through yet uncharacterized mechanisms.
Among myeloid lineage cells, dendritic cells (DCs) require a relatively well-characterized lncRNA named Lnc-DC, which is highly expressed by differentiating myeloid DC progenitors. Knockdown experiments in vitro and in vivo have shown that Lnc-DC regulates DC development. It appears that Lnc-DC directly associates with the STAT3 transcription factor in the cytoplasm by RNA-protein interaction and promotes its phosphorylation through shielding STAT3 from dephosphorylation at the Tyr705 residue by the phosphatase SHP-1 (24) . Although such shielding activity is often observed in proteinprotein interactions, Lnc-DC was the first lncRNA identified to shield the associating protein to inhibit dephosphorylation by masking a target residue.
Monocyte/macrophage lineage differentiation also requires regulation by an lncRNA named Lnc-MC (25) . Expression of Lnc-MC is highly up-regulated during monocyte/macrophage differentiation from HSCs, and the transcription is regulated by the transcription factor PU.1, a critical transcription factor for many lineages of immune cells. Interestingly, miR199a-5p, a miRNA transcribed in a PU.1-dependent manner, is a negative regulator of monocyte/macrophage differentiation (26) . This suggested that a regulatory network involving an lncRNA and a miRNA is used to regulate target genes in a positive and negative way, respectively. In cell lines, induction of Lnc-MC expression suppresses miR-199a-5 expression, and induced miR-199a-5 expression inhibits lnc-MC expression (25) , which suggested the presence of another unique reciprocal cross-regulation between an lncRNA and a miRNA.
The HOX gene cluster regulates crucial steps in numerous developmental processes, and prevalent transcriptional activities are detected on intergenic areas, similar to those on other developmentally important genomic regions (27) , which can be one of the indicators of ncRNAs. In fact, the international research consortiums FANTOM (Functional Annotation of the Mammalian Genome) and ENCODE (Encyclopedia of DNA Elements) have revealed numerous potential lncRNAs surrounding the HOX gene cluster. For example, an ncRNA named HOTAIRM1 (HOXA transcript anti-sense RNA, myeloid-specific 1) was found to be expressed from the HOX cluster (28) . HOTAIRM1 is specifically expressed during myelopoiesis and regulates myelocyte differentiation.
Moreover, shRNA-mediated knockdown of HOTAIRM1 in myeloid cell lines revealed that retinoic acid-dependent activation of the HOXA1 or the HOXA4 gene requires HOTAIRM1 transcripts. Another lncRNA named Linc-HOXA1 was reported to regulate HOXA1 gene expression in cis (29) . These discoveries of multiple lncRNAs required for myelopoiesis in the Hox gene cluster suggest that several lncRNAs cooperate with each other to regulate the expression of developmentally important genes as seen in the case of enzymes. This kind of cooperative action of factors with redundant functions is a common mechanism for enzymes and is used to set regulatory thresholds at fine levels.
Roles of lncRNAs during innate immune responses
In this section, we will discuss how lncRNAs play a role in the regulation of immune responses by modulating the functions of innate types of immune cells. This section is therefore subdivided according to cell types expressing such lncRNAs.
Dendritic cells
A genomic approach was applied to identify ncRNAs associated with the innate immune system, such as in CD11c + bone-marrow-derived DCs after activating NF-κB signaling thorough stimulation of TLR4 (30) . This method revealed about 20 lncRNAs that were up-regulated specifically upon this stimulation. Although this study did not characterize all individual lncRNAs identified from the screening, the results suggested a potential association between lncRNAs and inflammatory responses. In particular, an lncRNA named LincRNA-CoX2 garnered attention since it was expressed near the Cox2 gene (~30 kb downstream of Cox2), a critical target of the NF-κB signaling cascade. Interestingly, a later study found that another lncRNA, named PACER (p50-associated COX-2 extragenic RNA), transcribed from the upstream region of the Cox2 promoter is essential to activate the Cox2 gene as it dissociates repressive p50 dimers of NF-κB from the Cox2 promoter (31). However, further studies are necessary to determine whether LincRNA-CoX2 and PACER regulate DC functions by directly regulating Cox2 expression.
Interestingly, the Lnc-DC lncRNA important for DC development (described in the previous section) plays another role in regulating DC function during T-cell priming (24) . It seems that Lnc-DC positively regulates the expression of several genes important for DC function, such as CD40, CD80 and CD86 co-stimulatory molecules. Knockdown assays revealed that the down-regulation of Lnc-DC inhibits proper antigen presentation and cytokine production by DCs. This indicates that Lnc-DC is a multifunctional molecule acting at two different stages.
Macrophages/monocytes
The same group of researchers who identified LincRNA-CoX2 further screened lncRNAs in macrophages after stimulation with LPS to induce TLR signaling. This led to an isolation of LincRNA-EPS, which was previously implicated in erythropoiesis. This lncRNA showed high expression in macrophages as well as in erythrocyte progenitors, but was markedly down-regulated after LPS stimulation (22, 32) . LincRNA-EPS-knockout mice exhibited augmented inflammation and increased lethality after endotoxin challenges, which indicated that LincRNA-EPS plays the role of an immune suppressor. Detailed analysis indicated that LincRNA-EPS represses genes associated with pro-inflammatory responses. It seems that LincRNA-EPS directly associates with heterogeneous nuclear ribonucleoprotein L (hnRNPL), an RNA-binding protein, to induce repressive epigenetic modifications on target genes such as Cxcl10, Ccl5 and Pycard.
A similar approach from another group revealed that an lncRNA named THRIL (TNF-α and hnRNPL-related immunoregulatory lincRNA) is specifically expressed after stimulation of macrophages with TNF-α (33). Once expressed, THRIL forms a ribonucleoprotein (RNP) complex with hnRNPL, similarly to LincRNA-EPS, and binds to the TNF-α promoter for direct transcriptional activation as well as to promoters of other pro-inflammatory genes. Furthermore, THRIL was believed to operate as part of a negative feedback loop based on the fact that high TNF-α expression down-regulates the expression of THRIL. Therefore, it appears that two lncRNAs-LincRNA-EPS and THRIL-regulate the expression of NF-κB downstream target genes in macrophages negatively and positively, respectively (34) .
An eRNA named IL-1β-eRNA has also been implicated in inflammatory responses after NF-κB signaling. IL-1β-eRNA is lncRNAs and immune responses 169 transcribed from the intronic region in the Il1b locus and is specifically expressed after the activation of NF-κB signaling through LPS stimulation in monocytes. It negatively regulates many genes important for pro-inflammatory responses, such as IL-1β (35) . Two other ncRNAs, a non-coding anti-sense transcript of Il1b and IL-1β-RBT46 (RBT stands for region of bidirectional transcription), are also transcribed from the Il1b locus (35, 36) . Anti-sense-IL-1β transcript appears to negatively regulate the local Il1b gene by altering histone modifications and IL-1β-RBT46 seems to positively regulate IL-1β, indicating that IL-1β is regulated by at least three ncRNAs.
Other lncRNAs are also involved in the regulation of inflammatory responses independently from NF-κB signaling. For example, expression of several important antiviral factors such as IL-8 and CCL5 requires the expression of an lncRNA NEAT1 (nuclear-enriched abundant transcript 1) in response to poly I:C, influenza virus infection or herpes simplex virus infection (37) . It is also interesting that lncRNA NEAT1 was originally discovered as an essential structural component for the formation of a nuclear body called paraspeckles (38) . In paraspeckles, lncRNA NEAT1 is associated with the SFPQ (splicing factor proline/glutamine-rich) repressor protein.
Since lncRNA NEAT1 transcripts are not abundant, some SFPQs are also present outside of paraspeckles and bind to the Il8 promoter to suppress Il8 transcription in the normal state. Since viral infection sharply up-regulates lncRNA NEAT1 levels, extra lncRNA NEAT1 transcripts after infection can sequester SFPQs from the Il8 promoter and hold them in paraspeckles, thus releasing the Il8 gene from SFPQmediated repression. Therefore, relocation of SFPQ from the Il8 promoter to paraspeckles by lncRNA NEAT1 is an important axis for innate immunity during viral infection.
Granulocytes
A recently discovered lncRNA named Morrbid (myeloid RNA regulator of Bim-induced death) regulates the lifespan of granulocytes including monocytes, eosinophils and neutrophils by the transcriptional repression of a nearby gene Bim (Bcl2l11), which has been known for its pro-apoptotic property (39) . The lifespans of circulating granulocytes have important consequences since inappropriate regulation of granulocyte proliferation can lead to the development of autoimmune diseases or cancers. The genetic disruption of Morrbid in mice led to a severe reduction in the number of circulating granulocytes and increased Bim expression, without affecting other cell lineages such as lymphocytes and mast cells. In fact, the researchers showed that human MORRBID exhibits dysregulated expression patterns in hypereosinophilic syndrome patients. The detailed molecular mechanism of MORRBID-dependent repression is yet to be characterized, but it appears to involve transcriptional regulation by polycomb repressive complex 2 (PRC2).
Fibroblasts
In this review, we focused on lncRNAs expressed from hematopoietic cells, but some lncRNAs expressed from fibroblasts or epithelial cells also have been shown to be involved in immune responses. For example, an lncRNA named Lethe, a transcript from the Rps15a pseudogene (Rps15a-ps4), was originally identified during lncRNA screening after stimulation of mouse embryonic fibroblasts with TNF-α (40). Although several lncRNAs were specifically up-regulated and downregulated during the stimulation, Lethe was notable because it was up-regulated only in response to TNF-α and not in response to TLR antagonists, which indicated its involvement in selective inflammatory signaling. Knockdown of Lethe resulted in the up-regulation of NF-κB target genes such as Il6 and Il8. It was therefore suggested that Lethe antagonizes the activity of NF-κB presumably by inhibiting DNA binding of the NF-κB complex. This inhibition by Lethe could be achieved by inhibiting the DNA-binding activity of RelA, a known NF-κB effector subunit, through direct and inducible association with RelA.
Roles of lncRNAs during adaptive immune responses
Recent studies have begun to discover lncRNAs as important regulators of acquired immunity. Here, we will describe lncRNAs known for their roles, mainly in T-cell mediated immunity, since very little is known about lncRNAs in B-cell functions.
T h 1 type responses
A well-conserved lncRNA named NeST (Nettoie Salmonella pas Theiler's; also known as Ifng-AS1 or TMEVPG1) is transcribed from near the Ifng gene and is selectively expressed from T h 1 cells by the actions of Stat4 and T-bet, which are known T h 1-signature transcription factors (41) . NeST seems to positively regulate IFN-γ expression in either cis or trans through epigenetic modification of the Ifng locus by binding to WDR5, one of the components in H3K4 methyltransferase complexes. The relevance of IFN-γ induction by NeST in activated CD8 + T cells was confirmed by its roles in Theiler's virus persistence and in Salmonella infection (42) .
Another study that specifically surveyed lincRNA in human T lymphocytes identified a lincRNA, which also turned out to be linked with T h 1 responses. This approach revealed a total of 1500 lincRNAs, and ~180 lincRNAs showed T h 1-specific expression patterns (43) . Among such T h 1-specific lincRNAs, a lincRNA named Linc-MAF-4 showed the highest expression. Further functional characterizations of Linc-MAF-4 revealed that it promotes T h 1 differentiation by repressing the expression of a T h 2-specific transcription factor, MAF. This suppressive function seems to be mediated by the recruitment of chromatin modifiers to the promoter region of the Maf gene, similarly to NeST.
T h 2 type responses
A landmark study using 42 human T-cell samples including cells at various developmental stages revealed ~1500 lncRNAs. Not surprisingly, most of these lncRNAs expressed in specific T-cell populations were transcribed from intergenic regions located close to the genes involved in immune-regulatory functions and exhibited specific expression patterns depending on the effector T-cell subtype (44) . For instance, a lincRNA named LincR-Ccr2-5′AS was found to be transcribed from the CCR chemokine receptor cluster in the antisense orientation to the Ccr2 gene in T h 2 cells. Knockdown of LincR-Ccr2-5′AS resulted in the down-regulation of several Ccr transcripts from the cluster. In addition, induced LincRCcr2-5′AS expression enhanced the expression of T h 2-specific genes in conjunction with the GATA3 transcription factor, which is central for T h 2 differentiation. However, the molecular mechanism by which LincR-Ccr2-5′AS controls the transcription of its target genes and manipulates T h 2 responses remains unclear.
T h 17 type responses
A study aimed at identifying a new binding partner for RORγt, an orphan nuclear receptor essential for T h 17 cell differentiation, discovered DDX5 (DEAD box RNA helicase protein 5). Interestingly, the interaction of DDX5 with RORγt was found to depend on the RNA helicase domain of DDX5, suggesting a possibility that RNA molecules participate in this association. Then, RNAs interacting with DDX5 were screened using RNA immunoprecipitation assays, which resulted in the identification of an lncRNA named Rmrp. Rmrp is expressed specifically in T h 17 cells and interacts with DDX5 (45) . Interestingly, a mutation in Rmrp was found in patients with cartilage-hair hypoplasia. Generation of a mutant mouse line with the exact mutation of the above-mentioned patients revealed that this mutation indeed reduced DDX5-RORγt interaction and RORγt target gene transcription.
As a result of the screening of gene products enriched upon growth inhibition by starvation or rapamycin in T cells, an ncRNA transcribed within the GAS5 (growth arrest-specific 5) gene was identified (46) . GAS5 ncRNA is classified as a 5′ TOP (5′ terminal oligopyrimidine tract) RNA, the expression of which is induced by the mTOR pathway important for T h 1/T h 17 differentiation (47, 48) even though it is not clear whether GAS5 ncRNA is directly involved in the differentiation of T h 17. GAS5 ncRNA has a peculiar structure: its introns host an array of snoRNAs and its exons contain numerous nonfunctional small open reading frames (ORFs).
A recent study illustrated the functional mechanism of GAS5 ncRNA by showing that a stem-loop region of GAS5 ncRNA mimics the conformation of the GRE (glucocorticoid receptor response element) sequence on the genome. Thus, GAS5 ncRNA acts as a decoy of GRE and inhibits glucocorticoid receptor binding to GRE by sequestering. This stops the expression of genes in response to glucocorticoids, and many of these genes are anti-apoptotic. Therefore, increased expression of GAS5 ncRNA resulting in the repression of glucocorticoid-responsive genes upon T-cell growth arrest is thought to sensitize cells to apoptosis during starvation to save energy (49) .
Conclusions
The number of lncRNAs being reported has grown at an astonishing rate due to the various screenings conducted for the differential expression of ncRNAs; however, the molecular aspects of their functions remain largely unexplored. Therefore, there is a lack of information regarding the functional domains, binding partners or nature of catalytic function of many of the identified lncRNAs. This is mainly due to the fact that most lncRNAs lack obvious sequence similarities between species, which results in lower conservation compared with that of protein counterparts. Researchers have not yet even reached a consensus on whether the sequence conservation levels of lncRNAs are at least above the background levels (50, 51) .
It is not even clear whether lncRNAs need sequence conservation since ncRNAs have less-rigid sequence requirements for their structures and might require very short stretches to form minimum functional domains. A recent observation supports this notion by showing that the sequence conservation of lncRNA promoters is higher than that of the promoters for protein-coding genes, even though the transcribed sequences of lncRNAs have much less conservation (52) .
Interestingly, recent discoveries also show that some lncRNAs might encode peptides, albeit the lengths of ORFs for them are much shorter than usual (53) (54) (55) (56) (57) . On the contrary, in addition to their usual function as transmitters of DNA information to ribosomes, some mRNAs encoding proteins might have additional functions as regulatory RNAs (58) . This suggests that a classical categorization that distinguishes ncRNAs from coding RNAs based on the coding potential will not be straightforward in the future.
In addition, it has become evident that a large portion of annotated lncRNAs might in fact be eRNAs. Since the strong transcriptional activities of enhancers generate huge amounts of unstable transcripts, it is not easy to distinguish lncRNAs from eRNAs when lncRNAs are transcribed from uncharacterized enhancers (59) . Some specific features such as shorter lengths, higher instabilities and lack of structural domains including introns or 3′ UTRs have been suggested for eRNAs (60) . However, it is not clear as to how many of these features are useful. Clearer criteria to define eRNAs will be set as more lncRNAs and eRNAs are discovered and as the enhancer landscape is updated.
Lack of information regarding sequence conservation and functional domains in lncRNAs has resulted in researchers hesitating to generate animal models for loss-of-function studies by editing genome sequences. In addition, generating knockout models for lncRNAs always involves risks of removing genome functions as regulatory regions. Therefore, most researches have relied on knockdown approaches to reduce the expression of lncRNA in order to determine their functions. Although these approaches are useful for uncovering the biological aspects regulated by lncRNAs, experimental tools that provide mechanical insights into lncRNA action are still limited. Advances in computational models based on well-characterized lncRNAs, which will be updated in a timely way with upcoming novel lncRNA characterization, will be one way to build a solid experimental framework and to advance our knowledge of the structures of lncRNAs.
Funding
The preparation of this manuscript was supported by grantsin-aid awarded to W.S. from the Ministry of Education, Culture, Sports, and Technology of Japan.
References

